Bindu Varghese
About Bindu Varghese
Bindu Varghese is a Senior Director at Sana Biotechnology, Inc., with expertise in tumor immunology and immunotherapy techniques. She has played a significant role in the development of REGN1979 and has extensive experience in managing and mentoring scientists.
Current Role at Sana Biotechnology
Bindu Varghese serves as Senior Director at Sana Biotechnology, Inc. since 2021. In this role, she applies her extensive expertise in tumor immunology and immunotherapy techniques to advance the company's research initiatives. Her leadership contributes to the development of innovative therapies aimed at treating various cancers.
Previous Experience at Regeneron
Varghese worked at Regeneron from 2012 to 2017, holding positions as Scientist and Staff Scientist. During her tenure, she played a key role in the development of REGN1979, Regeneron's first bispecific antibody, which progressed to a Phase I clinical trial for non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) patients. Her work focused on tumor immunology and inflammation.
Education and Expertise
Varghese earned her PhD in Chemistry from Purdue University, where she studied from 2000 to 2006. She then completed postdoctoral studies in Immunology/Oncology at Stanford University School of Medicine from 2006 to 2009 and at Harvard Medical School from 2010 to 2012. Her educational background supports her specialization in immunotherapy techniques, including adoptive T cell transfer therapy.
Experience at Incyte
From 2017 to 2021, Varghese held the position of Associate Director at Incyte in the Greater Philadelphia Area. In this role, she contributed to the company's research efforts in oncology, leveraging her extensive background in immunology and drug development.
Patents and Research Contributions
Varghese holds nine filed patents related to targeted imaging, drug delivery, bispecific technology, and humanized mouse models. Her research contributions include designing and executing in vitro and in vivo assays, as well as conducting complex data analysis and interpretation, demonstrating her commitment to advancing scientific knowledge in her field.